Literature DB >> 23295714

Sevoflurane suppresses tumour necrosis factor-α-induced inflammatory responses in small airway epithelial cells after anoxia/reoxygenation.

K Watanabe1, C Iwahara, H Nakayama, K Iwabuchi, T Matsukawa, K Yokoyama, K Yamaguchi, Y Kamiyama, E Inada.   

Abstract

BACKGROUND: Lung ischaemia-reperfusion (I/R) injury is correlated with poor clinical outcome. The inflammatory cytokines interleukin (IL)-6, IL-8, and monocyte chemotactic protein-1 (MCP-1) are produced by pulmonary epithelial cells during lung transplantation and are considered to be involved in I/R injury. The volatile anaesthetic sevoflurane has been shown to exert a protective effect on I/R injury in various organs. We investigated the effect of sevoflurane on the inflammatory functions of pulmonary epithelial cells in vitro.
METHODS: Human normal small airway epithelial cells (SAEC) were incubated under anoxic conditions for 24 h with or without sevoflurane and then stimulated with tumour necrosis factor (TNF)-α under hyperoxic conditions for 5 h with or without sevoflurane. After incubation, IL-6, IL-8, and MCP-1 mRNA expression was analysed by quantitative real-time RT-PCR. The production of IL-6, IL-8, and MCP-1 was assayed by enzyme-linked immunosorbent assay, the effects of sevoflurane on inflammatory gene expression were examined by DNA microarray analysis, and the effects of sevoflurane on NF-κB-mediated inflammatory cytokine production were examined by immunoblotting.
RESULTS: Sevoflurane suppressed TNF-α-induced IL-6, IL-8, and MCP-1 gene expression and the production of IL-6 and IL-8 in SAEC under anoxia/reoxygenation conditions. DNA microarray analysis indicated that sevoflurane modulated NF-κB-related gene expression. Sevoflurane significantly inhibited TNF-α-induced translocation of p65 NF-κB into the nucleus. Sevoflurane enhanced TNF-α-induced gene expression of inhibitor κB (IκB) but not of NF-κB.
CONCLUSIONS: Sevoflurane suppressed the NF-κB-mediated production of pulmonary epithelial cell-derived inflammatory cytokines, including IL-6 and IL-8, which are capable of causing I/R injury.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23295714     DOI: 10.1093/bja/aes469

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  12 in total

1.  Effects of volatile vs. propofol-based intravenous anesthetics on the alveolar inflammatory responses to one-lung ventilation: a meta-analysis of randomized controlled trials.

Authors:  Bin Sun; Jinfeng Wang; Lulong Bo; Yan Zang; Haihui Gu; Jinbao Li; Baohua Qian
Journal:  J Anesth       Date:  2015-02-26       Impact factor: 2.078

2.  The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis.

Authors:  Lily Nahidi; Susan M Corley; Marc R Wilkins; Jerry Wei; Moftah Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  Genes Nutr       Date:  2015-07-17       Impact factor: 5.523

Review 3.  Lung protective properties of the volatile anesthetics.

Authors:  Brian O'Gara; Daniel Talmor
Journal:  Intensive Care Med       Date:  2016-07-04       Impact factor: 17.440

4.  Sevoflurane Promotes Bactericidal Properties of Macrophages through Enhanced Inducible Nitric Oxide Synthase Expression in Male Mice.

Authors:  Thomas J Gerber; Valérie C O Fehr; Suellen D S Oliveira; Guochang Hu; Randal Dull; Marcelo G Bonini; Beatrice Beck-Schimmer; Richard D Minshall
Journal:  Anesthesiology       Date:  2019-12       Impact factor: 7.892

5.  Cardioprotective Effects of Astragalin against Myocardial Ischemia/Reperfusion Injury in Isolated Rat Heart.

Authors:  Daoxu Qu; Jichun Han; Huanhuan Ren; Wenxiao Yang; Xinjie Zhang; Qiusheng Zheng; Dong Wang
Journal:  Oxid Med Cell Longev       Date:  2015-12-16       Impact factor: 6.543

Review 6.  Immunomodulatory effects of anesthetics in obese patients.

Authors:  Luciana Boavista Barros Heil; Pedro Leme Silva; Paolo Pelosi; Patricia Rieken Macedo Rocco
Journal:  World J Crit Care Med       Date:  2017-08-04

7.  Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction.

Authors:  Hui Wang; Daoyuan Lv; Song Jiang; Qing Hou; Lei Zhang; Shen Li; Xiaodong Zhu; Xiaodong Xu; Jianqiang Wen; Caihong Zeng; Mingchao Zhang; Fan Yang; Zhaohong Chen; Chunxia Zheng; Jing Li; Ke Zen; Zhihong Liu; Limin Li
Journal:  Cell Death Dis       Date:  2022-03-29       Impact factor: 8.469

8.  Cardioprotection against ischemia/reperfusion by licochalcone B in isolated rat hearts.

Authors:  Jichun Han; Dong Wang; Bacui Yu; Yanming Wang; Huanhuan Ren; Bo Zhang; Yonghua Wang; Qiusheng Zheng
Journal:  Oxid Med Cell Longev       Date:  2014-08-21       Impact factor: 6.543

9.  Plasma kynurenic acid concentration in patients undergoing cardiac surgery: effect of anaesthesia.

Authors:  Edyta Kotlinska-Hasiec; Patrycja Nowicka-Stazka; Jolanta Parada-Turska; Krzysztof Stazka; Janusz Stazka; Przemyslaw Zadora; Wojciech Dabrowski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-09-10       Impact factor: 4.291

10.  Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti-inflammatory microglia/macrophages phenotype polarization through GSK-3β/Nrf2 pathway.

Authors:  Min Cai; Sisi Sun; Jin Wang; Beibei Dong; Qianzi Yang; Li Tian; Hailong Dong; Shiquan Wang; Wugang Hou
Journal:  CNS Neurosci Ther       Date:  2021-08-09       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.